These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 28482693)

  • 1. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Norrish G; Cantarutti N; Pissaridou E; Ridout DA; Limongelli G; Elliott PM; Kaski JP
    Eur J Prev Cardiol; 2017 Jul; 24(11):1220-1230. PubMed ID: 28482693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.
    Christiaans I; van Engelen K; van Langen IM; Birnie E; Bonsel GJ; Elliott PM; Wilde AA
    Europace; 2010 Mar; 12(3):313-21. PubMed ID: 20118111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).
    Norrish G; Ding T; Field E; Ziólkowska L; Olivotto I; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Bökenkamp R; Baban A; Kubuš P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Marrone C; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Castro FJ; Stuart G; Vignati G; Barriales-Villa R; Guereta LG; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Rasmussen TB; Calcagnino MM; Jones CB; De Wilde H; Toru-Kubo J; Felice T; Mogensen J; Mathur S; Reinhardt Z; O'Mahony C; Elliott PM; Omar RZ; Kaski JP
    JAMA Cardiol; 2019 Sep; 4(9):918-927. PubMed ID: 31411652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy.
    Miron A; Lafreniere-Roula M; Steve Fan CP; Armstrong KR; Dragulescu A; Papaz T; Manlhiot C; Kaufman B; Butts RJ; Gardin L; Stephenson EA; Howard TS; Aziz PF; Balaji S; Ladouceur VB; Benson LN; Colan SD; Godown J; Henderson HT; Ingles J; Jeewa A; Jefferies JL; Lal AK; Mathew J; Jean-St-Michel E; Michels M; Nakano SJ; Olivotto I; Parent JJ; Pereira AC; Semsarian C; Whitehill RD; Wittekind SG; Russell MW; Conway J; Richmond ME; Villa C; Weintraub RG; Rossano JW; Kantor PF; Ho CY; Mital S
    Circulation; 2020 Jul; 142(3):217-229. PubMed ID: 32418493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validation study of the European Society of Cardiology guidelines for risk stratification of sudden cardiac death in childhood hypertrophic cardiomyopathy.
    Norrish G; Ding T; Field E; McLeod K; Ilina M; Stuart G; Bhole V; Uzun O; Brown E; Daubeney PEF; Lota A; Linter K; Mathur S; Bharucha T; Kok KL; Adwani S; Jones CB; Reinhardt Z; Omar RZ; Kaski JP
    Europace; 2019 Oct; 21(10):1559-1565. PubMed ID: 31155643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Schinkel AF; Vriesendorp PA; Sijbrands EJ; Jordaens LJ; ten Cate FJ; Michels M
    Circ Heart Fail; 2012 Sep; 5(5):552-9. PubMed ID: 22821634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validation study of the 2003 American College of Cardiology/European Society of Cardiology and 2011 American College of Cardiology Foundation/American Heart Association risk stratification and treatment algorithms for sudden cardiac death in patients with hypertrophic cardiomyopathy.
    O'Mahony C; Tome-Esteban M; Lambiase PD; Pantazis A; Dickie S; McKenna WJ; Elliott PM
    Heart; 2013 Apr; 99(8):534-41. PubMed ID: 23339826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy.
    Norrish G; Ding T; Field E; Cervi E; Ziółkowska L; Olivotto I; Khraiche D; Limongelli G; Anastasakis A; Weintraub R; Biagini E; Ragni L; Prendiville T; Duignan S; McLeod K; Ilina M; Fernández A; Marrone C; Bökenkamp R; Baban A; Kubus P; Daubeney PEF; Sarquella-Brugada G; Cesar S; Klaassen S; Ojala TH; Bhole V; Medrano C; Uzun O; Brown E; Gran F; Sinagra G; Castro FJ; Stuart G; Vignati G; Yamazawa H; Barriales-Villa R; Garcia-Guereta L; Adwani S; Linter K; Bharucha T; Garcia-Pavia P; Siles A; Rasmussen TB; Calcagnino M; Jones CB; De Wilde H; Kubo T; Felice T; Popoiu A; Mogensen J; Mathur S; Centeno F; Reinhardt Z; Schouvey S; O'Mahony C; Omar RZ; Elliott PM; Kaski JP
    Circ Arrhythm Electrophysiol; 2022 May; 15(5):e010075. PubMed ID: 35491873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverted U-Shaped Relation Between the Risk of Sudden Cardiac Death and Maximal Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy.
    O'Mahony C; Jichi F; Monserrat L; Ortiz-Genga M; Anastasakis A; Rapezzi C; Biagini E; Gimeno JR; Limongelli G; McKenna WJ; Omar RZ; Elliott PM;
    Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27217341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy.
    Patel SI; Ackerman MJ; Shamoun FE; Geske JB; Ommen SR; Love WT; Cha SS; Bos JM; Lester SJ
    Acta Cardiol; 2019 Feb; 74(1):53-58. PubMed ID: 29513133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and outcomes of hypertrophic cardiomyopathy in young adults.
    Baron É; Karam N; Donal E; Puscas T; Mirabel M; Bacher A; Wahbi K; Mazzella JM; Jeunemaitre X; Reant P; Hagège A;
    Arch Cardiovasc Dis; 2021; 114(6-7):465-473. PubMed ID: 33744178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Kamp NJ; Chery G; Kosinski AS; Desai MY; Wazni O; Schmidler GS; Patel M; Lopes RD; Morin DP; Al-Khatib SM
    Prog Cardiovasc Dis; 2021; 66():10-16. PubMed ID: 33171204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
    Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
    Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.
    Magnusson P; Gadler F; Liv P; Mörner S
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):291-301. PubMed ID: 26681505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Conway J; Min S; Villa C; Weintraub RG; Nakano S; Godown J; Tatangelo M; Armstrong K; Richmond M; Kaufman B; Lal AK; Balaji S; Power A; Baez Hernandez N; Gardin L; Kantor PF; Parent JJ; Aziz PF; Jefferies JL; Dragulescu A; Jeewa A; Benson L; Russell MW; Whitehill R; Rossano J; Howard T; Mital S
    Circulation; 2023 Feb; 147(9):718-727. PubMed ID: 36335467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the 2014 European Society of Cardiology Sudden Cardiac Death Risk Prediction Model Among Various Phenotypes in Japanese Patients With Hypertrophic Cardiomyopathy.
    Nakagawa S; Okada A; Nishimura K; Hamatani Y; Amano M; Takahama H; Amaki M; Hasegawa T; Kanzaki H; Kusano K; Yasuda S; Izumi C
    Am J Cardiol; 2018 Dec; 122(11):1939-1946. PubMed ID: 30293654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
    Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
    J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D; Ye M; Zhang L; Jiang B
    Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.